NCT07713537Recruiting
Risk Score of Embolism in Patients With AF Undergoing DOAC Therapy
Risk Score of Embolism in Patients With Atrial Fibrillation (AF) Undergoing Treatment With Direct Oral Anticoagulant (DOAC)
Source: ClinicalTrials.gov · Last updated 20 Jul 2026
Brief summary (registry, in English)
Acute ischaemic strokes occur despite the use of direct oral anticoagulants (DOACs). Evidence-based scale is necessary to assess ischemic stroke risk in atrial fibrillation (AF) patients.
- Status (registry)
- Recruiting
- Study type
- Observational
- Enrollment
- 250 (estimated)
- First submitted
- 12 Jan 2026
- Start date
- 1 Jan 2025
- Primary completion date
- 31 Dec 2027
- Lead sponsor
- Hospital Universitari Vall d'Hebron Research Institute
- Diseases
- Stroke, Atrial fibrillation
- NCT number
- NCT07713537
What you commit to
- Study type: Observational
- Planned participants: 250
- From 1 Jan 2025 to the primary completion date, 31 Dec 2027
- 2 sites in 1 country
- Visits and tests: ask the trial team, the registry does not list them
Built from the registry fields of ClinicalTrials.gov. It describes the study, not your situation.
Who cannot take part
Copied verbatim from ClinicalTrials.gov and grouped by topic. Only the trial team decides who can take part.
Other
- Patient with valvular AF (mitral stenosis) or mechanical valve prostheses.
- Unable to complete a follow-up period of at least 3 months from enrollment.
Who the study is looking for
- Patient over 18 years of age
- History of AD
- Currently on DOACs.
- Capacity to understand the study procedures and provide informed consent.
Sex: All · Accepts healthy volunteers
Sites (2)
Sites in registry order. Pick your city on the disease page to sort them by distance.
| Site | City | Country | Site status |
|---|---|---|---|
| Vall d'Hebron University Hospital Coordinator of this site? Confirm its status | Barcelona | Spain | Recruiting |
| Germans Trias University Hospital Coordinator of this site? Confirm its status | Barcelona | Spain | Recruiting |
This page is information, not medical advice. Discuss any trial with your doctor.